License to Improvements. Licensee hereby grants to Licensor a worldwide, fully paid-up, royalty-free, non-exclusive license, with the right to sublicense through multiple tiers, under any Improvements, solely for purposes of Developing, Manufacturing, and Commercializing the Licensed Compound and Licensed Product, in each case for Japan (subject to the exclusive rights granted to Licensee under this Agreement with respect to the Licensed Product and the Licensed Compound in the Territory).
License to Improvements. During the term of this Agreement, DYTECH shall deliver to AMEDICA a reasonably detailed written description of any Improvement (the “Improvement Notice”). The Improvement Notice shall be delivered to AMEDICA as soon as practicable after DYTECH develops or discovers the Improvement, but in any event prior to disclosure of such Improvement to any Third Party (except DYTECH’S own professional Third Party patent advisors and lawyers, each of which will be subject to written confidentiality obligations no less stringent than those contained herein). AMEDICA shall have the exclusive right and option, exercisable for a period of [*************] after its receipt of the Improvement Notice, to include the Improvement within the scope of the exclusive license grant Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Company’s application requesting confidential treatment under Rule 406 of the Securities Act of 1933, as amended. of Section 3.1 above by delivering to DYTECH a written notice (the “Exercise Notice”) to such effect. If AMEDICA delivers an Exercise Notice for any Improvement, the scope of the exclusive license grant of Section 3.1 above shall, without any further payment by AMEDICA, be deemed to include such Improvement thereafter.
License to Improvements. Subject to the terms and conditions hereof, ALPHARMA hereby grants to IDEA a nonexclusive, royalty-free, perpetual license, with the right to grant sublicenses subject to the terms hereof, under the Improvements Controlled by ALPHARMA which are made at any time after the Effective Date but before the date of the First Commercial Sale of the first Licensed Product in the U.S., to make, have made, use, sell, offer for sale and import Products outside the Territory and to conduct clinical trials and manufacture Products within the Territory for the purpose of making, having made, using, selling, offering for sale and importing Products solely outside the Territory and to perform IDEA's obligations pursuant to Section 5.1.
License to Improvements. Virgin hereby grants to MAV a worldwide, royalty-free, non-sublicenseable, non-exclusive license during the term of this Agreement and thereafter to all improvements and enhancements to the items set forth in clauses (a) and (b) of Section 1.6 above, to the extent that such improvements and enhancements are created, invented or first reduced to practice by or on behalf of Virgin or its Affiliates (“Virgin IP”) prior to the expiration of [***] after the Effective Date, for the sole purpose of developing, constructing, importing, promoting, testing and operating spacecraft for its own benefit.
License to Improvements. Licensee may include any patent application claims covering Improvements as a Licensed Patent under this Agreement at no additional cost other than the costs set forth in this Agreement by providing written notice to Licensor within [***] days after publication of such patent application identifying the Improvement patent applications Licensee chooses to include as a Licensed Patent. If Licensor concurs with such determination, such patent applications will be deemed to be a Licensed Patent effective on Licensee’s notice to Licensor in accordance with Section 14.5 of this Agreement. Option & Exclusive License Agreement
License to Improvements. Bioamber hereby grants DuPont a non-exclusive, royalty-free license, to any and all Improvements outside the Commercial Field.
License to Improvements. BMS hereby grants to GI a non-exclusive, ----------------------- royalty-free license to all Improvements, including the right to grant sublicenses, for the sole and exclusive purpose of (a) producing bulk NPA both within and outside the Territory, but only for distribution and sale outside the Territory, (b) developing, using, registering, formulating, filling and finishing, distributing and/or selling Licensed Products outside the Territory and (c) in the event that the Option, the licenses granted to BMS in this Agreement and this Agreement expire or terminate for any reason without BMS having exercised the Option, distributing and selling bulk NPA within the Territory and developing, using, registering, formulating, filling and finishing, distributing and/or selling Licensed Products within the Territory.
License to Improvements. The License Agreement shall contain ----------------------- provisions comparable to those set forth in Section 3.5 of this Agreement, provided that the provisions of Section 3.5(c) of this Agreement shall apply to any termination of the License Agreement not due to GI's breach of the License Agreement.
License to Improvements. Section 3.6 of the Agreement is hereby deleted in its entirety and replaced with the following: License to Improvements. Virgin hereby grants, and shall cause its Affiliates to grant, to MAV a worldwide, royalty-free, perpetual, non-exclusive license to all improvements and enhancements to the items set forth in clauses (a) and (b) of Section 1.6 above, to the extent that such improvements and enhancements are or have been created, invented or first reduced to practice by or on behalf of Virgin or its Affiliates (“Virgin IP”) prior to the end of the Exclusivity Period. Such license includes the right (a) to grant sublicenses thereunder at any time in the Space Tourism Market and (b) to grant sublicenses thereunder with effect at any time following the Exclusivity Period in any market or for any areas or activities.
License to Improvements. Inpixon may elect to include any GTX patent application covering an Improvement as a Licensed Patent under this Agreement by providing written notice to GTX within sixty (60) Business Days after receipt of GTX’s notice identifying the Improvement patent application. Each such Improvement patent application will be deemed to be a Licensed Patent effective on Inpixon’s notice to GTX.
